Drug intelligence / Profile preview

Fastjel

Development stage
Unknown
Lead developer
Akdeniz University
Modality
Small Molecules
Administration
Topical
01

Overview

Fastjel is a topical gel formulation containing 2.5% ketoprofen, a non-steroidal anti-inflammatory drug (NSAID) of the propionic acid class. Developed and extensively studied by Akdeniz University, particularly in the context of emergency medicine, Fastjel is utilized for the localized treatment of mechanical low back pain. Its mechanism of action involves the non-selective inhibition of cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, which subsequently reduces the biosynthesis of prostaglandins responsible for pain and inflammation. By delivering the active ingredient topically, Fastjel aims to provide effective analgesia at the site of injury while minimizing the systemic exposure and associated adverse effects typically seen with oral or parenteral NSAIDs and opioids.

Brand names
Fastjel
Other names
2.5% ketoprofen gelketoprofen gel
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Fastjel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fastjel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call